NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3078% below fair value
$0.76+0.05 (+7.73%)
Close on Nov 18, 2026Market cap $6.93MP/E –Yield –
Neuroone Medical Technologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Neuroone Medical Technologies's free cash flow for the twelve months ending Jun 30, 2026 was -$7.16M. For fiscal 2025 it was -$2.92M. The highest annual figure on record is -$2.92M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$2.92M | – |
| FY2024 | Sep 30, 2024 | -$11.13M | – |
| FY2023 | Sep 30, 2023 | -$13.27M | – |
| FY2022 | Sep 30, 2022 | -$7.79M | – |
| FY2021 | Sep 30, 2021 | -$8.67M | – |
| FY2020 | Sep 30, 2020 | -$3.55M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$1.10M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$1.37M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$3.16M | -1819.0% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$1.54M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$1.51M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$59.32K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $183.63K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$2.70M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$2.38M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$2.21M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$3.85M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$2.96M | -411.1% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$3.08M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$3.73M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$3.50M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $951.64K | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.69M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$3.31M | -1632.5% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$2.74M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$2.06M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$2.32M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $216.31K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.25M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$1.28M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$1.24M | – |
See a number that looks wrong?